ClinicalTrials.Veeva

Menu

Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas (SUPATEEN)

M

Martin-Luther-Universität Halle-Wittenberg

Status

Completed

Conditions

Sarcoma
Brain Tumor
Cancer
Childhood Cancer
Leukemia
Adolescent Cancer

Treatments

Other: Non-Interventional

Study type

Observational

Funder types

Other

Identifiers

NCT04101123
70113424

Details and patient eligibility

About

Aim of this study is to investigate the influence of social factors on participation and activity among children and adolescents aged 10-18 years with leukemia, brain tumors, and sarcomas. Furthermore personal and treatment-related factors and their impact on participation will be explored

Full description

Background: About 2000 children and adolescents under the age of 18 develop cancer each year in Germany. Because of more differentiated diagnostics and standardized treatment protocols, a high survival rate can be reached for many types of the disease. Nevertheless, patients face a number of long-term effects related to the treatment. As a result, physical and psychological consequences have increasingly become the focus of research in recent years. Social dimensions of health have rarely been investigated in pediatric oncology so far. Yet, there are no robust results that allow an estimation of whether and to what extent the disease and treatment impair the participation of children and adolescents and which factors mediate this effect. Social participation is of great importance especially because interactions with peers and experiences in different areas of life are essential for the development of children and adolescents.

Methods: Data are collected in a longitudinal, prospective, observational multicenter study. For this purpose, all patients and their parents who are being treated for cancer in one of the participating clinics throughout Germany will be interviewed within the first month after diagnosis (t1), after completion of intensive treatment (t2) and half a year after the end of intensive treatment (t3) using standardized questionnaires. Analysis will be done by descriptive and multivariate methods.

Recruitment: Patients will be consecutively recruited in one of the participating clinics throughout Germany.

Enrollment

68 patients

Sex

All

Ages

10 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • newly diagnosed with confirmed leukemia, brain tumor or sarcoma
  • age 10-18 years
  • written informed consent of the patient and of one of the parents if they are under the age of 18

Exclusion criteria

  • having a relapse or secondary tumor
  • insufficient command of German
  • profound cognitive and physical impairments

Trial design

68 participants in 1 patient group

Children and adolescents with cancer
Description:
Children and adolescents between 10-18 years with newly diagnosed leukemia, brain tumors, and sarcomas
Treatment:
Other: Non-Interventional

Trial contacts and locations

1

Loading...

Central trial contact

Julia Roick, Dipl.-Soz.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems